Explore Janssen Alzheimer Immunotherapy's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 24, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 19, 2022Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease1